Folinic Acid Enhanced Cytotoxicity of Fluoropyrimidines In Human Breast Cancer Cells

This report describes the effects of the natural diastereoisomer of 5-formyltetrahydrofolate (6S)- and of the mixture of both the natural and unnatural diastereoisomers (6RS)-5-HCO-H4PteGlu (folinate) on the cytotoxicity of 5-fluoro-2′-deoxyuridine (FdUrd) and 5-fluorouracil (FUra) in MCF-7 and MDA-...

Full description

Bibliographic Details
Main Author: Mandelbaum-Shavit Frederika
Format: Article
Language:English
Published: De Gruyter 1993-02-01
Series:Pteridines
Subjects:
Online Access:https://doi.org/10.1515/pteridines.1993.4.1.51
_version_ 1818737976029478912
author Mandelbaum-Shavit Frederika
author_facet Mandelbaum-Shavit Frederika
author_sort Mandelbaum-Shavit Frederika
collection DOAJ
description This report describes the effects of the natural diastereoisomer of 5-formyltetrahydrofolate (6S)- and of the mixture of both the natural and unnatural diastereoisomers (6RS)-5-HCO-H4PteGlu (folinate) on the cytotoxicity of 5-fluoro-2′-deoxyuridine (FdUrd) and 5-fluorouracil (FUra) in MCF-7 and MDA-MB 231. human breast cancer cell lines. Continuous exposure of exponentially growing cells to various concentrations of FUra for 72 h caused a 50% inhibition of growth with lC50 at concentrations of 3.40± 0.16 and 29± 1.40 11M in MCF-7 and MDA-MB 231. respectively. Preincubation of the cells for 24 h with (6S)-5-CHO-H4PteGlu (5 µM) prior to addition of FUra decreased the IC50 values by 2.4-2.6-fold in both cell lines. A quantitatively similar effect was achieved by preincubation with ]() µM of (6RS)-5-HCO-H4PteGlu. The cytotoxicity of FdUrd was markedly more pronounced than that of FUra exhibiting IC50, values at a range of 0.045- 0.050 µM for both cell lines. Preincubation with (6S)-5-HCO-H4PteGlu increased the susceptibility to the drug by about 3.5-fold. The optimal dose of (6S)-5-CHO-H4PteGlu for achieving the lowest IC50 value for FdURd in MCF-7 cells was 5 µM. whereas that in MDA-MB 231 was 20 µM. Similar increase of the cytotoxicity of FdUrd was obtained with about a 2-fold higher concentration of (6RS)-5-HCO-H4PteGlu. Cells pretreated lor 24 h with FUra or FdUrd respectively. exhibited enhanced incorporation of [3H] thymidine into the TCA-precipitable fraction . Presence of (6S)-5-HCO-H4PteGlu (10 µM) doubled the amount of incorporated thymidine. which reflects depletion of intracellular thymidylate pools due to enhanced formation and stabilization of the complex formed between thymidylate synthase. flouorodeoxydylate and 5.1.0-methylenetetrahydrofolate.
first_indexed 2024-12-18T01:01:35Z
format Article
id doaj.art-00fef072342b487f958197d41e4a1317
institution Directory Open Access Journal
issn 0933-4807
2195-4720
language English
last_indexed 2024-12-18T01:01:35Z
publishDate 1993-02-01
publisher De Gruyter
record_format Article
series Pteridines
spelling doaj.art-00fef072342b487f958197d41e4a13172022-12-21T21:26:21ZengDe GruyterPteridines0933-48072195-47201993-02-0141515510.1515/pteridines.1993.4.1.51Folinic Acid Enhanced Cytotoxicity of Fluoropyrimidines In Human Breast Cancer CellsMandelbaum-Shavit Frederika0Department of Bacteriology, Hebrew University-Hadassah Medical SchooL Jerusalem, IsraelThis report describes the effects of the natural diastereoisomer of 5-formyltetrahydrofolate (6S)- and of the mixture of both the natural and unnatural diastereoisomers (6RS)-5-HCO-H4PteGlu (folinate) on the cytotoxicity of 5-fluoro-2′-deoxyuridine (FdUrd) and 5-fluorouracil (FUra) in MCF-7 and MDA-MB 231. human breast cancer cell lines. Continuous exposure of exponentially growing cells to various concentrations of FUra for 72 h caused a 50% inhibition of growth with lC50 at concentrations of 3.40± 0.16 and 29± 1.40 11M in MCF-7 and MDA-MB 231. respectively. Preincubation of the cells for 24 h with (6S)-5-CHO-H4PteGlu (5 µM) prior to addition of FUra decreased the IC50 values by 2.4-2.6-fold in both cell lines. A quantitatively similar effect was achieved by preincubation with ]() µM of (6RS)-5-HCO-H4PteGlu. The cytotoxicity of FdUrd was markedly more pronounced than that of FUra exhibiting IC50, values at a range of 0.045- 0.050 µM for both cell lines. Preincubation with (6S)-5-HCO-H4PteGlu increased the susceptibility to the drug by about 3.5-fold. The optimal dose of (6S)-5-CHO-H4PteGlu for achieving the lowest IC50 value for FdURd in MCF-7 cells was 5 µM. whereas that in MDA-MB 231 was 20 µM. Similar increase of the cytotoxicity of FdUrd was obtained with about a 2-fold higher concentration of (6RS)-5-HCO-H4PteGlu. Cells pretreated lor 24 h with FUra or FdUrd respectively. exhibited enhanced incorporation of [3H] thymidine into the TCA-precipitable fraction . Presence of (6S)-5-HCO-H4PteGlu (10 µM) doubled the amount of incorporated thymidine. which reflects depletion of intracellular thymidylate pools due to enhanced formation and stabilization of the complex formed between thymidylate synthase. flouorodeoxydylate and 5.1.0-methylenetetrahydrofolate.https://doi.org/10.1515/pteridines.1993.4.1.51folinic acidcytotoxicityfluoropyrimidineshuman breast cancer cell lines
spellingShingle Mandelbaum-Shavit Frederika
Folinic Acid Enhanced Cytotoxicity of Fluoropyrimidines In Human Breast Cancer Cells
Pteridines
folinic acid
cytotoxicity
fluoropyrimidines
human breast cancer cell lines
title Folinic Acid Enhanced Cytotoxicity of Fluoropyrimidines In Human Breast Cancer Cells
title_full Folinic Acid Enhanced Cytotoxicity of Fluoropyrimidines In Human Breast Cancer Cells
title_fullStr Folinic Acid Enhanced Cytotoxicity of Fluoropyrimidines In Human Breast Cancer Cells
title_full_unstemmed Folinic Acid Enhanced Cytotoxicity of Fluoropyrimidines In Human Breast Cancer Cells
title_short Folinic Acid Enhanced Cytotoxicity of Fluoropyrimidines In Human Breast Cancer Cells
title_sort folinic acid enhanced cytotoxicity of fluoropyrimidines in human breast cancer cells
topic folinic acid
cytotoxicity
fluoropyrimidines
human breast cancer cell lines
url https://doi.org/10.1515/pteridines.1993.4.1.51
work_keys_str_mv AT mandelbaumshavitfrederika folinicacidenhancedcytotoxicityoffluoropyrimidinesinhumanbreastcancercells